|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1998-6-18
|
|
pubmed:abstractText |
Infants with acute lymphoblastic leukemia (ALL) often enter remission; however, they have a high rate of relapse. To prevent relapse, infants' tolerance of and benefits from early intensive rotating drug pairs as part of therapy were studied.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1077-4114
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
229-33
|
|
pubmed:dateRevised |
2011-10-6
|
|
pubmed:meshHeading |
pubmed-meshheading:9628434-6-Mercaptopurine,
pubmed-meshheading:9628434-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9628434-Cytarabine,
pubmed-meshheading:9628434-Daunorubicin,
pubmed-meshheading:9628434-Disease-Free Survival,
pubmed-meshheading:9628434-Drug Therapy, Combination,
pubmed-meshheading:9628434-Female,
pubmed-meshheading:9628434-Humans,
pubmed-meshheading:9628434-Hydrocortisone,
pubmed-meshheading:9628434-Infant,
pubmed-meshheading:9628434-Injections, Spinal,
pubmed-meshheading:9628434-Male,
pubmed-meshheading:9628434-Methotrexate,
pubmed-meshheading:9628434-Pilot Projects,
pubmed-meshheading:9628434-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:9628434-Remission Induction,
pubmed-meshheading:9628434-Teniposide
|
|
pubmed:articleTitle |
Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot Study.
|
|
pubmed:affiliation |
Emory University School of Medicine, Department of Pediatrics, Atlanta, Georgia 30322, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
